125
Views
13
CrossRef citations to date
0
Altmetric
Research Article

Loss of lysophosphatidic acid receptor-3 suppresses cell migration activity of human sarcoma cells

, , , , , & show all
Pages 328-334 | Received 26 Jun 2012, Accepted 08 Oct 2012, Published online: 20 Nov 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Toshifumi Tsujiuchi, Miku Hirane, Yan Dong & Nobuyuki Fukushima. (2014) Diverse effects of LPA receptors on cell motile activities of cancer cells. Journal of Receptors and Signal Transduction 34:3, pages 149-153.
Read now
Mutsumi Araki, Misaho Kitayoshi, Yan Dong, Miku Hirane, Shuhei Ozaki, Shiori Mori, Nobuyuki Fukushima, Kanya Honoki & Toshifumi Tsujiuchi. (2014) Inhibitory effects of lysophosphatidic acid receptor-5 on cellular functions of sarcoma cells. Growth Factors 32:3-4, pages 117-122.
Read now

Articles from other publishers (10)

Sung-Hee Hwang, Hye-Gyo Kim & Michael Lee. (2022) Paradoxical downregulation of LPAR3 exerts tumor-promoting activity through autophagy induction in Ras-transformed cells. BMC Cancer 22:1.
Crossref
Yu-Hsuan Lin, Yueh-Chien Lin & Chien-Chin Chen. (2021) Lysophosphatidic Acid Receptor Antagonists and Cancer: The Current Trends, Clinical Implications, and Trials. Cells 10:7, pages 1629.
Crossref
Karina Helivier Solís, M. Teresa Romero-Ávila, Alejandro Guzmán-Silva & J. Adolfo García-Sáinz. (2021) The LPA3 Receptor: Regulation and Activation of Signaling Pathways. International Journal of Molecular Sciences 22:13, pages 6704.
Crossref
Kaede Takahashi, Kanako Minami, Shiho Otagaki, Kaichi Ishimoto, Kaori Fukushima, Nobuyuki Fukushima, Kanya Honoki & Toshifumi Tsujiuchi. (2018) Lysophosphatidic acid receptor-2 (LPA2) and LPA5 regulate cellular functions during tumor progression in fibrosarcoma HT1080 cells. Biochemical and Biophysical Research Communications 503:4, pages 2698-2703.
Crossref
Kaede Takahashi, Kaori Fukushima, Kosuke Tanaka, Kanako Minami, Kaichi Ishimoto, Shiho Otagaki, Nobuyuki Fukushima, Kanya Honoki & Toshifumi Tsujiuchi. (2018) Involvement of LPA signaling via LPA receptor-2 in the promotion of malignant properties in osteosarcoma cells. Experimental Cell Research 369:2, pages 316-324.
Crossref
Kaede Takahashi, Kaori Fukushima, Nobuyuki Fukushima, Kanya Honoki & Toshifumi Tsujiuchi. (2017) Enhanced cellular functions through induction of LPA2 by cisplatin in fibrosarcoma HT1080 cells. Molecular and Cellular Biochemistry 431:1-2, pages 29-35.
Crossref
Shuhei Ishii, Yuka Kitamura, Miku Hirane, Ayaka Tomimatsu, Kaori Fukushima, Kaede Takahashi, Nobuyuki Fukushima, Kanya Honoki & Toshifumi Tsujiuchi. (2016) Negative effects of G-protein-coupled free fatty acid receptor GPR40 on cell migration and invasion in fibrosarcoma HT1080 cells. Molecular Carcinogenesis 55:11, pages 1553-1559.
Crossref
Jung Min Ryu & Ho Jae Han. (2015) Autotaxin-LPA Axis Regulates hMSC Migration by Adherent Junction Disruption and Cytoskeletal Rearrangement Via LPAR1/3-Dependent PKC/GSK3β/β-Catenin and PKC/Rho GTPase Pathways. Stem Cells 33:3, pages 819-832.
Crossref
Yan Dong, Miku Hirane, Mutsumi Araki, Nobuyuki Fukushima, Kanya Honoki & Toshifumi Tsujiuchi. (2014) Lysophosphatidic acid receptor-5 negatively regulates cell motile and invasive activities of human sarcoma cell lines. Molecular and Cellular Biochemistry 393:1-2, pages 17-22.
Crossref
Yan Liao, Ganggang Mu, Lingli Zhang, Wei Zhou, Jun Zhang & Honggang Yu. (2013) Lysophosphatidic Acid Stimulates Activation of Focal Adhesion Kinase and Paxillin and Promotes Cell Motility, via LPA1–3, in Human Pancreatic Cancer. Digestive Diseases and Sciences 58:12, pages 3524-3533.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.